Literature DB >> 17071138

ID proteins as targets in cancer and tools in neurobiology.

Antonio Iavarone1, Anna Lasorella.   

Abstract

In eukaryotic organisms, ID proteins are key regulators of development when they function to preserve the stem cell state and prevent lineage determination. By fueling several key features of tumor progression (deregulated proliferation, invasiveness, angiogenesis and metastasis), ID proteins contribute to multiple steps of tumorigenesis. Through oncogenic processes that lead to their aberrant activation in tumors, ID proteins transfer the phenotypic traits of embryonic stem cells to cancer cells. However, ID proteins have recently emerged as highly specialized factors in post-mitotic neurons. The elevated expression of ID proteins arrests neurons in the axon growth mode and prevents cessation of axonal elongation. Here, we discuss how unique properties of ID proteins in cancer cells and neurons pave the way to unexpected therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071138     DOI: 10.1016/j.molmed.2006.10.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  25 in total

1.  Type I bHLH Proteins Daughterless and Tcf4 Restrict Neurite Branching and Synapse Formation by Repressing Neurexin in Postmitotic Neurons.

Authors:  Mitchell D'Rozario; Ting Zhang; Edward A Waddell; Yonggang Zhang; Cem Sahin; Michal Sharoni; Tina Hu; Mohammad Nayal; Kaveesh Kutty; Faith Liebl; Wenhui Hu; Daniel R Marenda
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

2.  Inhibition of Daughterless by Extramacrochaetae mediates Notch-induced cell proliferation.

Authors:  Carrie M Spratford; Justin P Kumar
Journal:  Development       Date:  2015-05-14       Impact factor: 6.868

3.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

Review 4.  Palate morphogenesis: current understanding and future directions.

Authors:  Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res C Embryo Today       Date:  2010-06

5.  Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.

Authors:  Eva Grönroos; Isabel J Kingston; Anassuya Ramachandran; Rebecca A Randall; Pedro Vizán; Caroline S Hill
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

Review 6.  What is the clinical value of cancer stem cell markers in gliomas?

Authors:  Rikke Hedegaard Dahlrot; Simon Kjær Hermansen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

7.  Overexpression of Id3 induces apoptosis of A549 human lung adenocarcinoma cells.

Authors:  X-J Li; C-D Zhu; W Yu; P Wang; F-F Chen; X-Y Xia; B Luo
Journal:  Cell Prolif       Date:  2011-12-07       Impact factor: 6.831

8.  ID family protein expression and regulation in hypoxic pulmonary hypertension.

Authors:  Jonathan W Lowery; Andrea L Frump; Lynda Anderson; Gabriella E DiCarlo; Mark T Jones; Mark P de Caestecker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-29       Impact factor: 3.619

9.  Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Authors:  Yuanguang Meng; Chenglei Gu; Zhiqiang Wu; Yali Zhao; Yiling Si; Xiaobing Fu; Weidong Han
Journal:  BMC Cancer       Date:  2009-03-04       Impact factor: 4.430

10.  FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.

Authors:  Weidong Han; Zhiqiang Wu; Yali Zhao; Yuanguang Meng; Yiling Si; Jie Yang; Xiaobing Fu; Li Yu
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.